Iterum Therapeutics Plc (ITRM)

Jul 27, 2025

What institutional investors are buying Iterum Therapeutics plc stockUnlock daily stock market insights for success - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

What are analysts’ price targets for Iterum Therapeutics plc in the next 12 monthsCapitalize on high-yield stocks early - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

Iterum Therapeutics plc Company Revenue and Profit Trends: A Deep DiveFree Access to Investment Community - Newser

Jul 27, 2025

Jul 25, 2025

Iterum Therapeutics plc Stock Analysis and ForecastFree Stock Market Trend Analysis - PrintWeekIndia

Jul 25, 2025

Jul 24, 2025

Is Iterum Therapeutics plc a good long term investmentSuperior risk-adjusted returns - Autocar Professional

Jul 24, 2025

Jul 23, 2025

What drives Iterum Therapeutics plc stock priceConsistently exceptional gains - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Iterum Therapeutics Plc (ITRM) Stock: A Year of Market Movement, Down and Up - investchronicle.com

Jul 23, 2025

Jul 22, 2025

What analysts say about Iterum Therapeutics plc stockHigh-profit capital plays - jammulinksnews.com

Jul 22, 2025

Jul 15, 2025

Why Iterum Therapeutics plc stock attracts strong analyst attentionMassive Profit Potential - Newser

Jul 15, 2025

Jul 15, 2025

What makes Iterum Therapeutics plc stock price move sharplyWatchlist Winner Update - Newser

Jul 15, 2025

Jul 15, 2025

How Iterum Therapeutics plc stock performs during market volatilityFree Access to Investment Community - Newser

Jul 15, 2025

Jul 14, 2025

OneDigital Investment Advisors LLC Invests $124,000 in Iterum Therapeutics PLC (NASDAQ:ITRM) - Defense World

Jul 14, 2025

Jul 08, 2025

Iterum Therapeutics (NASDAQ:ITRM) Trading Down 4.2% – Here’s What Happened - Defense World

Jul 08, 2025

Jul 05, 2025

Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛

Jul 05, 2025

Jun 30, 2025

Iterum Strengthens Launch Strategy: 30-Year Pharma Veteran Christine Coyne to Lead ORLYNVAH Commercialization - Stock Titan

Jun 30, 2025

Jun 30, 2025

Iterum Names Christine Coyne as Chief Commercial Officer to Lead ORLYNVAH™ Launch and Commercial Growth - Yahoo Finance

Jun 30, 2025

Jun 29, 2025

Certain Options of Iterum Therapeutics plc are subject to a Lock-Up Agreement Ending on 30-JUN-2025. - MarketScreener

Jun 29, 2025

Jun 29, 2025

Certain Ordinary Shares of Iterum Therapeutics plc are subject to a Lock-Up Agreement Ending on 30-JUN-2025. - MarketScreener

Jun 29, 2025

Jun 25, 2025

Iterum Therapeutics (ITRM) Releases Positive Phase 3 Trial Resul - GuruFocus

Jun 25, 2025

Jun 25, 2025

Iterum Therapeutics (ITRM) Releases Positive Phase 3 Trial Results | ITRM Stock News - GuruFocus

Jun 25, 2025

Jun 25, 2025

New Antibiotic Shows Promise Against Drug-Resistant UTIs: NEJM Evidence Reveals 9.2% Multi-Resistance Rate - Stock Titan

Jun 25, 2025

Jun 17, 2025

Transcript : Iterum Therapeutics plcSpecial Call - MarketScreener

Jun 17, 2025

Jun 14, 2025

Research Analysts Set Expectations for ITRM FY2026 Earnings - Defense World

Jun 14, 2025

Jun 14, 2025

Two Sigma Investments LP Invests $45,000 in Iterum Therapeutics plc (NASDAQ:ITRM) - Defense World

Jun 14, 2025

Jun 13, 2025

EVERSANA expands commercialisation portfolio with OS Therapies and Iterum Therapeutics partnerships - pharmaphorum

Jun 13, 2025

Jun 12, 2025

Citadel Advisors LLC Acquires Shares of 21,207 Iterum Therapeutics plc (NASDAQ:ITRM) - Defense World

Jun 12, 2025

Jun 11, 2025

Iterum Therapeutics (ITRM) Partners with EVERSANA for U.S. Launc - GuruFocus

Jun 11, 2025

Jun 11, 2025

Iterum Therapeutics announces partnership with EVERSANA - PharmaLive

Jun 11, 2025

Jun 11, 2025

Iterum Therapeutics inks deal for ORLYNVAH commercialization By Investing.com - Investing.com Nigeria

Jun 11, 2025

Jun 11, 2025

Iterum Therapeutics inks deal for ORLYNVAH commercialization - Investing.com

Jun 11, 2025